Valproic acid: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
No edit summary
imported>David E. Volk
(chem infobox and structure)
Line 2: Line 2:
{{Chem infobox
{{Chem infobox
|align=right
|align=right
|image=[[Image:Valproic acid.jpg|center|thumb|125px]]  
|image=[[Image:Valproic acid.jpg|center|thumb|175px]]  
|width=125px
|width=175px
|molname=valproic acid
|molname=valproic acid
|synonyms=Abbott-44089; 2-Propylpentanoic acid; 2-Propylvaleric acid; di-n-dipropylacetic acid
|synonyms=Abbott-44089; 2-Propylpentanoic acid; 2-Propylvaleric acid; di-n-dipropylacetic acid
Line 13: Line 13:
|iupac=  
|iupac=  
|casnumber= 99-66-1
|casnumber= 99-66-1
}}
}}  
[[Image:Valproic acid.jpg|right|thumb|350px|{{#ifexist:Template:Valproic acid.jpg/credit|{{Valproic acid.jpg/credit}}<br/>|}}Add image caption here.]]
 
'''Valproic acid''' is a medication that is "a [[fatty acid]] with anticonvulsant properties used in the treatment of [[epilepsy]]; the sodium salt is used in treating [[mood disorders]]. It also is used for [[neurogenic pain]].
'''Valproic acid''' is a medication that is "a [[fatty acid]] with anticonvulsant properties used in the treatment of [[epilepsy]]; the sodium salt is used in treating [[mood disorders]]. It also is used for [[neurogenic pain]].



Revision as of 10:10, 29 June 2008

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
Valproic acid.jpg
valproic acid
IUPAC name:
Synonyms: Abbott-44089; 2-Propylpentanoic acid; 2-Propylvaleric acid; di-n-dipropylacetic acid
Formula: C8H16O2

 Uses: anticonvulsant

 Properties: fatty acid derivative

 Hazards:

Mass (g/mol): CAS #:
144.2 99-66-1


Valproic acid is a medication that is "a fatty acid with anticonvulsant properties used in the treatment of epilepsy; the sodium salt is used in treating mood disorders. It also is used for neurogenic pain.

The mechanisms of its therapeutic actions are not well understood. It may act by increasing gamma-aminobutyric acid levels in the brain or by altering the properties of voltage dependent sodium channels."[1]

Side effects

Valproic acid causes carnitine deficiency. All patients under valproate therapy should have their carnitine status monitored. Since available tests are not reliable indicators of carnitine status in tissues, prophylactic carnitine therapy can be considered. Intravenous carnitine is markedly superior to oral; oral acetylcarnitine may be advantageously used as well, if the underlying disorder allows it.

Benign hand tremor is not infrequent as a side effect, and can be suppressed, if there are no contraindications to their use, with beta-adrenergic antagonists.

External links

Valproic acid - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).


References